{{Rsnum
|rsid=17637703
|Gene=LARS2
|Chromosome=3
|position=45399229
|Orientation=plus
|GMAF=0.1708
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LARS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 41.6 | 3.5
| HCB | 83.2 | 15.3 | 1.5
| JPT | 83.2 | 15.9 | 0.9
| YRI | 91.1 | 8.9 | 0.0
| ASW | 82.5 | 15.8 | 1.8
| CHB | 83.2 | 15.3 | 1.5
| CHD | 82.6 | 17.4 | 0.0
| GIH | 65.0 | 32.0 | 3.0
| LWK | 94.5 | 5.5 | 0.0
| MEX | 50.0 | 43.1 | 6.9
| MKK | 76.3 | 21.8 | 1.9
| TSI | 42.6 | 51.5 | 5.9
| HapMapRevision=28
}}

A 2009 study of 11,163 Dutch participants found no evidence to support previous data indicating a role for SNPs in this gene ([[LARS2]]) in type 2 diabetes susceptibility.{{PMID|19847392|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}